RGNX
Regenxbio Inc
7.90$
-1.9%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +24.0% | -39.5% | +126.5% | +2,002.4% | -83.9% | +338.7% | +204.3% | -76.0% | -19.9% | -7.7% | +104.5% | |
| – | +49.3% | -36.2% | +78.2% | +464.1% | -14.5% | +333.4% | +45.1% | +5.2% | -31.8% | -9.8% | -39.5% | |
| – | +19.0% | -40.3% | +139.2% | +2,305.2% | -87.1% | +340.3% | +252.1% | -86.1% | -8.9% | -6.2% | +201.7% | |
| – | +248.3% | +163.2% | +25.8% | +46.6% | +48.1% | +33.9% | +9.1% | +33.6% | -4.2% | -10.2% | +9.5% | |
| – | +209.3% | +98.0% | +15.4% | +35.3% | +40.6% | +23.2% | +24.3% | +7.5% | +3.8% | -13.4% | +8.1% | |
| – | +232.7% | +136.5% | +22.6% | +42.8% | +45.7% | +35.3% | +8.6% | +24.2% | +0.0% | -11.8% | +10.0% | |
| – | – | – | – | – | -269.1% | – | – | -264.3% | – | – | – | |
| – | -93.8% | -100.0% | – | – | – | -99.3% | +3,308.2% | -11.5% | -70.5% | +84.5% | +255.5% | |
| – | – | – | – | – | -193.6% | – | – | -298.5% | – | – | – | |
| – | -120.6% | – | – | +509.2% | -165.9% | – | +155.9% | -100.6% | – | – | – | |
| – | – | – | – | – | -194.8% | – | – | -319.3% | – | – | – | |
| – | – | – | – | – | -198.1% | – | – | -237.9% | – | – | – |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.